Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PDT, CPG

/R E P E A T -- Media Invitation - A Mobile Hospital to Increase Treatment Capacity for COVID-19 Patients/


POINTE-CLAIRE, QC, April 24, 2020 /CNW Telbec/ - The Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal would like to invite media representatives to visit the mobile hospital before it opens its doors to COVID-19 patients. Once open, the mobile hospital will increase treatment capacity and optimize care services for patients on our territory. 

Ms. Lynne McVey, President and CEO of the CIUSSS de l'Ouest-de-l'Île-de-Montréal,
Ms. Manon Barbe, LaSalle borough mayor, and
Mr. Pascal Mathieu, Canadian Red Cross Vice-President for Québec, will be on hand.

The visit will be carried out while respecting social distancing and instructions from the MSSS and Public Health concerning hygiene and security.

 

WHEN:

Sunday, April 26, 2020, at 1:00 pm



WHERE:

Jacques-Lemaire Arena
8181 Champlain Blvd.
Montréal, QC H8P 1B8

 

Note: Ms. Lynne McVey, President and CEO of the CIUSSS de l'Ouest-de-l'Île-de-Montréal, Ms. Manon Barbe, LaSalle borough mayor, and Mr. Patrick Mathieu, Canadian Red Cross Vice-President for Québec, will be available for one-on-one interviews with the media.  

SOURCE Centre intégré universitaire de santé et de services sociaux de l'Ouest-de-l'Île-de-Montréal


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: